Alzamend Neuro, Inc. Common Stock (ALZN) is a publicly traded Healthcare sector company. As of July 22, 2026, ALZN trades at $1.34 with a market cap of $4.79M and a P/E ratio of -0.12. ALZN moved +5.56% today. Year to date, ALZN is -27.47%; over the trailing twelve months it is -59.51%. Its 52-week range spans $0.84 to $12.06. Rallies surfaces ALZN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Alzamend Neuro, Inc. Common Stock (ALZN) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ALZN moved +5.56% today.
| Metric | Value |
|---|---|
| Price | $1.34 |
| Market Cap | $4.79M |
| P/E Ratio | -0.12 |
| EPS | $-11.32 |
| Dividend Yield | 0.00% |
| 52-Week High | $12.06 |
| 52-Week Low | $0.84 |
| Volume | 66.18K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $4.50M |
| Gross Margin | 0.00% |
ALZN analyst coverage data. Average price target: $0.00.